160 related articles for article (PubMed ID: 37906702)
1. Machine Learning-Based Drug Repositioning of Novel Janus Kinase 2 Inhibitors Utilizing Molecular Docking and Molecular Dynamic Simulation.
Yasir M; Park J; Han ET; Park WS; Han JH; Kwon YS; Lee HJ; Chun W
J Chem Inf Model; 2023 Nov; 63(21):6487-6500. PubMed ID: 37906702
[TBL] [Abstract][Full Text] [Related]
2. Drug Repositioning via Graph Neural Networks: Identifying Novel JAK2 Inhibitors from FDA-Approved Drugs through Molecular Docking and Biological Validation.
Yasir M; Park J; Han ET; Park WS; Han JH; Chun W
Molecules; 2024 Mar; 29(6):. PubMed ID: 38542998
[TBL] [Abstract][Full Text] [Related]
3. Vismodegib Identified as a Novel COX-2 Inhibitor via Deep-Learning-Based Drug Repositioning and Molecular Docking Analysis.
Yasir M; Park J; Han ET; Park WS; Han JH; Kwon YS; Lee HJ; Chun W
ACS Omega; 2023 Sep; 8(37):34160-34170. PubMed ID: 37744812
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation.
Wang Z; Sun L; Xu Y; Liang P; Xu K; Huang J
J Transl Med; 2023 Aug; 21(1):579. PubMed ID: 37641144
[TBL] [Abstract][Full Text] [Related]
5. Shape-based Machine Learning Models for the Potential Novel COVID-19 Protease Inhibitors Assisted by Molecular Dynamics Simulation.
Nayarisseri A; Khandelwal R; Madhavi M; Selvaraj C; Panwar U; Sharma K; Hussain T; Singh SK
Curr Top Med Chem; 2020; 20(24):2146-2167. PubMed ID: 32621718
[TBL] [Abstract][Full Text] [Related]
6. Development of machine learning models based on molecular fingerprints for selection of small molecule inhibitors against JAK2 protein.
Belenahalli Shekarappa S; Kandagalla S; Lee J
J Comput Chem; 2023 Jun; 44(16):1493-1504. PubMed ID: 36929511
[TBL] [Abstract][Full Text] [Related]
7. Discovering the Active Ingredients of Medicine and Food Homologous Substances for Inhibiting the Cyclooxygenase-2 Metabolic Pathway by Machine Learning Algorithms.
Tian Y; Zhang Z; Yan A
Molecules; 2023 Sep; 28(19):. PubMed ID: 37836625
[TBL] [Abstract][Full Text] [Related]
8. De novo design of dual-target JAK2, SMO inhibitors based on deep reinforcement learning, molecular docking and molecular dynamics simulations.
He L; Liu J; Zhao HL; Zhang LC; Yu RL; Kang CM
Biochem Biophys Res Commun; 2023 Jan; 638():23-27. PubMed ID: 36436338
[TBL] [Abstract][Full Text] [Related]
9. Drug repositioning of herbal compounds via a machine-learning approach.
Kim E; Choi AS; Nam H
BMC Bioinformatics; 2019 May; 20(Suppl 10):247. PubMed ID: 31138103
[TBL] [Abstract][Full Text] [Related]
10. Multiscale Virtual Screening Optimization for Shotgun Drug Repurposing Using the CANDO Platform.
Hudson ML; Samudrala R
Molecules; 2021 Apr; 26(9):. PubMed ID: 33925237
[TBL] [Abstract][Full Text] [Related]
11.
Azevedo PHRA; Peçanha BRB; Flores-Junior LAP; Alves TF; Dias LRS; Muri EMF; Lima CHDS
J Biomol Struct Dyn; 2024; 42(3):1417-1428. PubMed ID: 37054524
[TBL] [Abstract][Full Text] [Related]
12. Checking the STEP-Associated Trafficking and Internalization of Glutamate Receptors for Reduced Cognitive Deficits: A Machine Learning Approach-Based Cheminformatics Study and Its Application for Drug Repurposing.
Jamal S; Goyal S; Shanker A; Grover A
PLoS One; 2015; 10(6):e0129370. PubMed ID: 26066505
[TBL] [Abstract][Full Text] [Related]
13. Identification of new potential candidates to inhibit EGF via machine learning algorithm.
Torabi M; Yasami-Khiabani S; Sardari S; Golkar M; Pérez-Sánchez H; Ghasemi F
Eur J Pharmacol; 2024 Jan; 963():176176. PubMed ID: 38000720
[TBL] [Abstract][Full Text] [Related]
14. Machine Learning Models Based on Molecular Fingerprints and an Extreme Gradient Boosting Method Lead to the Discovery of JAK2 Inhibitors.
Yang M; Tao B; Chen C; Jia W; Sun S; Zhang T; Wang X
J Chem Inf Model; 2019 Dec; 59(12):5002-5012. PubMed ID: 31746601
[TBL] [Abstract][Full Text] [Related]
15. Multi-Dimensional Screening Strategy for Drug Repurposing with Statistical Framework-A New Road to Influenza Drug discovery.
Rohini K; Ramanathan K; Shanthi V
Cell Biochem Biophys; 2019 Dec; 77(4):319-333. PubMed ID: 31559538
[TBL] [Abstract][Full Text] [Related]
16. A Robust Machine Learning Framework Built Upon Molecular Representations Predicts CYP450 Inhibition: Toward Precision in Drug Repurposing.
Ouzounis S; Panagiotopoulos V; Bafiti V; Zoumpoulakis P; Cavouras D; Kalatzis I; Matsoukas MT; Katsila T
OMICS; 2023 Jul; 27(7):305-314. PubMed ID: 37406257
[TBL] [Abstract][Full Text] [Related]
17. A gastrointestinal locally activating Janus kinase inhibitor to treat ulcerative colitis.
Bu Y; Traore MDM; Zhang L; Wang L; Liu Z; Hu H; Wang M; Li C; Sun D
J Biol Chem; 2023 Dec; 299(12):105467. PubMed ID: 37979913
[TBL] [Abstract][Full Text] [Related]
18. Identification of kinase inhibitors that rule out the CYP27B1-mediated activation of vitamin D: an integrated machine learning and structure-based drug designing approach.
Mahajan K; Verma H; Choudhary S; Raju B; Silakari O
Mol Divers; 2021 Aug; 25(3):1617-1641. PubMed ID: 34272637
[TBL] [Abstract][Full Text] [Related]
19. An ensemble machine learning model generates a focused screening library for the identification of CDK8 inhibitors.
Lin TE; Yen D; HuangFu WC; Wu YW; Hsu JY; Yen SC; Sung TY; Hsieh JH; Pan SL; Yang CR; Huang WJ; Hsu KC
Protein Sci; 2024 Jun; 33(6):e5007. PubMed ID: 38723187
[TBL] [Abstract][Full Text] [Related]
20. Multi-stage virtual screening of natural products against p38α mitogen-activated protein kinase: predictive modeling by machine learning, docking study and molecular dynamics simulation.
Yang R; Zha X; Gao X; Wang K; Cheng B; Yan B
Heliyon; 2022 Sep; 8(9):e10495. PubMed ID: 36105464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
